approval · primary record
GALLIUM GA-68 GOZETOTIDE
2 approval events · latest 2025-03-28
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2025-03-28 |
| Approval events | 2 |
| Brand | LOCAMETZ |
| Sponsor | NOVARTIS |
| Route | INTRAVENOUS |
Approval history
2 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2025-03-28 | FDA | NDA | LOCAMETZ | NOVARTIS | INTRAVENOUS |
| 2025-03-20 | FDA | NDA | GOZELLIX | TELIX INNOVATIONS | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:32:09.438Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:gallium-ga-68-gozetotide
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Gallium Ga-68 Gozetotide · compound